[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Learn & Grow Together [@_GrowTogether_](/creator/twitter/_GrowTogether_) on x XXX followers Created: 2025-07-23 14:30:28 UTC #SenoresPharma Q1 Update: ✅ CONS Net Profit: ₹197M vs ₹107M YoY ✅ Revenue: ₹1.38B vs ₹804M YoY ✅ EBITDA: ₹341M vs ₹213M YoY ✅ EBITDA Margin: XXXXX% vs XXXXX% YoY #Pharma #Q1Results #StockMarket #Investing #Earnings #IndianMarkets XX engagements  **Related Topics** [investment](/topic/investment) [stockmarket](/topic/stockmarket) [Post Link](https://x.com/_GrowTogether_/status/1948027939917889670)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Learn & Grow Together @GrowTogether on x XXX followers
Created: 2025-07-23 14:30:28 UTC
#SenoresPharma Q1 Update:
✅ CONS Net Profit: ₹197M vs ₹107M YoY ✅ Revenue: ₹1.38B vs ₹804M YoY ✅ EBITDA: ₹341M vs ₹213M YoY ✅ EBITDA Margin: XXXXX% vs XXXXX% YoY
#Pharma #Q1Results #StockMarket #Investing #Earnings #IndianMarkets
XX engagements
Related Topics investment stockmarket
/post/tweet::1948027939917889670